171P Combining tumor-infiltrating lymphocytes and PD-L1 expression can stratify prognosis in early-stage triple-negative breast cancer patients who did not receive adjuvant chemotherapy

Authors :: Tatsunori Shimoi
Yasuyuki Kojima
Kazuki Sudo
K. Yamamoto
Miwa Yoshida
T. Murata
Kan Yonemori
Hitomi Sumiyoshi Okuma
Shin Takayama
Shu Yazaki
A. Suto
S. Kita
Emi Noguchi
Maki Tanioka
Tadaaki Nishikawa
Source :: Annals of Oncology. 32:S434
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Adjuvant chemotherapy
Tumor-infiltrating lymphocytes
business.industry
Internal medicine
medicine
Pd l1 expression
Hematology
Stage (cooking)
business
Triple-negative breast cancer

Full Text Access

Tools